1. Temperature dependence of Congo red binding to amyloid β12–28
- Author
-
Ruel E. McKnight, Kazushige Yokoyama, and Douglas R. Jackson
- Subjects
Circular dichroism ,Magnetic Resonance Spectroscopy ,Protein Conformation ,Amyloid beta ,Biophysics ,Plasma protein binding ,Calorimetry ,Buffers ,chemistry.chemical_compound ,Protein structure ,Alzheimer Disease ,Binding site ,Amyloid beta-Peptides ,biology ,Circular Dichroism ,Temperature ,Congo Red ,Isothermal titration calorimetry ,General Medicine ,Hydrogen-Ion Concentration ,Peptide Fragments ,Congo red ,Crystallography ,Models, Chemical ,chemistry ,biology.protein ,Protein Binding - Abstract
Because Congo red (CR) can bind to critical intermediate structural forms of amyloid beta (Aβ), it has been suggested as a potential therapeutic agent against neurodegenerative disorders such as Alzheimer’s disease. In this study, the interaction of CR with Aβ12–28 was investigated by use of isothermal titration calorimetry (ITC). Studies conducted between 15 and 35 °C show that binding of CR to Aβ12–28 was strongly dependent on temperature, with a decrease in CR–Aβ12–28 complexation as temperature increases, presumably because of conformational changes within Aβ12–28 at the highest temperatures, that conceal the CR binding sites. In fact, no CR binding was observed at 35 °C. The binding of CR to Aβ12–28 was associated with favorable changes in both enthalpy and entropy that resulted in binding constants (K) of between 105 and 106 M −1. An early (and more intense) entropy-driven CR disaggregation phase (K ~107–108 M −1) was observed before the onset of CR–Aβ12–28 complexation. Only CR disaggregation was observed at 35 °C. These results may provide further insights into the ability of CR to inhibit Aβ toxicity in neurodegenerative diseases.
- Published
- 2013